Development of integrated treatment solutions to induce cell death in diseased and abnormally proliferating tissues. Photodynamic therapy platforms directed to cancer, eye and cardiovascular disease
Light Sciences is developing a series of therapeutic solutions for the treatment of proliferative diseases based on a new model of Photodynamic Therapy (PDT) called Light Infusion Technology(TM) (Litx(TM)) platform.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
Light Sciences
34931 SE Douglas Street
Suite 200
Snoqualmie
Washington
98065 Washington
All rights reserved. Terms and Conditions | Contact us
